EGF mutant receptor vIII as a molecular target in cancer therapy.
Publication
, Journal Article
Kuan, CT; Wikstrand, CJ; Bigner, DD
Published in: Endocr Relat Cancer
June 2001
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Endocr Relat Cancer
DOI
ISSN
1351-0088
Publication Date
June 2001
Volume
8
Issue
2
Start / End Page
83 / 96
Location
England
Related Subject Headings
- Oncology & Carcinogenesis
- Neoplasms
- Mutation
- Immunotoxins
- Immunotherapy
- Humans
- Glioblastoma
- Gene Expression Regulation, Neoplastic
- ErbB Receptors
- Antibodies, Monoclonal
Citation
APA
Chicago
ICMJE
MLA
NLM
Kuan, C. T., Wikstrand, C. J., & Bigner, D. D. (2001). EGF mutant receptor vIII as a molecular target in cancer therapy. Endocr Relat Cancer, 8(2), 83–96. https://doi.org/10.1677/erc.0.0080083
Kuan, C. T., C. J. Wikstrand, and D. D. Bigner. “EGF mutant receptor vIII as a molecular target in cancer therapy.” Endocr Relat Cancer 8, no. 2 (June 2001): 83–96. https://doi.org/10.1677/erc.0.0080083.
Kuan CT, Wikstrand CJ, Bigner DD. EGF mutant receptor vIII as a molecular target in cancer therapy. Endocr Relat Cancer. 2001 Jun;8(2):83–96.
Kuan, C. T., et al. “EGF mutant receptor vIII as a molecular target in cancer therapy.” Endocr Relat Cancer, vol. 8, no. 2, June 2001, pp. 83–96. Pubmed, doi:10.1677/erc.0.0080083.
Kuan CT, Wikstrand CJ, Bigner DD. EGF mutant receptor vIII as a molecular target in cancer therapy. Endocr Relat Cancer. 2001 Jun;8(2):83–96.
Published In
Endocr Relat Cancer
DOI
ISSN
1351-0088
Publication Date
June 2001
Volume
8
Issue
2
Start / End Page
83 / 96
Location
England
Related Subject Headings
- Oncology & Carcinogenesis
- Neoplasms
- Mutation
- Immunotoxins
- Immunotherapy
- Humans
- Glioblastoma
- Gene Expression Regulation, Neoplastic
- ErbB Receptors
- Antibodies, Monoclonal